Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Background There is no therapy that can stop the progression of primary sclerosing cholangitis (PSC). Statins provide some benefits to patients with chronic liver diseases, so we performed a nationwide population-based study of patients with in PSC to determine their effects. Findings Use of statins and azathioprine were associated with reduced risk of death and liver transplantation in patients with PSC. Ursodeoxycholic acid was not associated with a reduced risk of death.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
